The Prognosis of Metastatic Gastrointestinal Cancer
- Publisher's listprice GBP 79.99
-
40 482 Ft (38 555 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 4 048 Ft off)
- Discounted price 36 434 Ft (34 700 Ft + 5% VAT)
40 482 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 1 October 2024
- ISBN 9781032699714
- Binding Paperback
- No. of pages252 pages
- Size 254x178 mm
- Weight 453 g
- Language English
- Illustrations 17 Illustrations, black & white; 17 Line drawings, black & white; 90 Tables, black & white 650
Categories
Short description:
The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.
MoreLong description:
Survival of patients with metastatic cancer has increased over the past two decades as a result of a progressive improvement of regional and systemic therapies. However, oncologists' estimates of patients' predicted overall survival in metastatic cancer are imprecise. The purpose of this book is to systematize the evidence regarding the prognostic factors of metastatic gastrointestinal tumors, separating the findings with the highest level of evidence among those available for each disease by selecting studies with the highest scientific evidence level.
MoreTable of Contents:
Introduction.
1. Esophageal cancer. 2. Gastric cancer. 3. Small bowel adenocarcinoma. 4. Pancreatic adenocarcinoma. 5. Hepatocellular carcinoma. 6. Biliary tract cancer. 7. Neuroendocrine neoplasms. 8. Gastro-intestinal stromal tumors. 9. Colorectal cancer. 10. Anal cancer.
Index.
More
